[Results of an open therapeutic trial with naproxen in patients with degenerative joint diseases].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007403:Intervertebral Disc; D007596:Joints / Q000503:physiopathology; D008297:Male; D008738:Methyl Ethers / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D009281:Naphthalenes / Q000008:administration & dosage / Q000627:therapeutic use; D010003:Osteoarthritis / Q000188:drug therapy; D011422:Propionates / Q000008:administration & dosage / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000503:physiopathology; D012737:Sex Factors; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D013997:Time Factors
D008738:Methyl Ethers; D009281:Naphthalenes; D011422:Propionates
Ergebnisse eines offenen Therapieversuches mit Naproxen bei Patienten mit degenerativen Gelenkerkrankungen.